Second Half Flashcards

1
Q

Host response to biomaterial implantation

A
  1. Injury
  2. Protein adhesion/blood material interaction
  3. Acute/chronic inflammation
  4. Granulation Tissue
  5. Foreign body reaction
  6. Fibrosis/fibrous capsule development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leukocytes

A

-White blood cells
-made in the bone marrow and found in the blood and lymph tissue
-Immune

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Neutrophil

A

Most abundant type of leukocytes (granulocyte)
-First responders (innate - non specific)
-Phagocytosis, ingest foreign bodies
-early stages of the immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Eosinophil

A

Acid loving, allergies (leukocyte, granulocyte)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Basophil

A

Base loving, allergies (leukocyte, granulocyte)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Monocyte

A

-Largest leukocyte
-Innate/adaptive immune system
-Found in circulation
-Differentiate into macrophages at the site of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Macrophage

A

-Phagocytosis, tissue residing
Types: M1 (inflammatory), M2 (wound healing/remodeling)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lymphocyte

A

-Adaptive immune response
-Produce antibodies
Types: T & B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Two types of responses you can get to biomaterials

A
  1. Foreign body response
  2. Acute or Chronic Inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Foreign body response

A

Isolate the foreign body from healthy tissue
-non-specific inflammation
-very broad recognition capabilities and no direct mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acute or Chronic Inflammation

A

Macrophages (M1/M2), Foreign Body Giant Cells, Frustrated Macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

M1 Macrophage

A

inflammatory, gets rid of foreign bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

M2 Macrophage

A

wound healing/remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Foreign Body Giant Cells (FBGC)

A

-Infused monocytes + macrophages that become multi nucleated singe cells (severe inflammatory reaction)
-involved in less biocompatible materials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Frustrated Macrophages

A

-phagocyte (ingest foreign bodies)
-mass dependent - creates frustration!
-release harmful enzymes/chemical mediators, deteriorate both the implant/surrounding tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Specific Response Immunity to Tissue Derived Biomaterials

A

Specific markers called antigens, our body is trained to recognize the foreign body even before we are exposed to them (flu)
-May express foreign antigens capable of eliciting an immune
response (immune reaction does not necessarily cause device
disfunction or rejection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Modified Koch’s Postulates for Biomaterials

A
  1. Determine the antigen specific elements (antibodies/cells) that are directly associated with a failed biomaterial
  2. The antibodies/cells from the first experiment animal (host) should be transferred to a second animal (host) and should cause the same failure
  3. The transferred elements (antigen, specific elements) should be detectable on the failed device (biomaterial) in the second host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to determine if a failure of a device is linked to an immunological reaction?

A

Biomaterial scientist have adapted postulates developed by German physician Robert Koch (1843-1910) :
-Originally used to determine if an infectious agent (e.g. pathogen) was responsible for a specific disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sequence of host responses following biomaterial implantation
1. Protein adsorption, blood/biomaterial interaction

A

-protein adsorption within seconds of contact
-controlling protein adsorption key to controlling host response
-as little as 5ng/cm2 protein increases platelet adhesion 20x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Amino Acid Structure

A

-amino (nitrogen group)
-R group
-Carboxyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Primary Protein Structure

A

Sequence of a chain of amino acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Secondary Protein Structure

A

Local folding of the polypeptide chain into helices or sheets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tertiary Protein

A

3D dimensional patter due to side chain interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Quaternary Protein

A

Protein consisting of more than one amino acid chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Amino Acids have different

A

charges, hydrophobicity, functional groups, reactivities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Plasma

A

Whole blood minus erythrocytes (RBCs), leukocytes (WBCs) and thrombocytes (platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How much water/solids does plasma contain

A

91%-92& water, 8%-9% solids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Three common proteins

A

albumin, globulins, fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Alubmin

A

4-6g/100mL plasma, 60% of proteins
-MW = 66kDA, 580 amino acids, single chain
-Regulate osmotic pressure (80% of osmotic gradient)
-Transport fatty acids (liver tissues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Globulins

A

1g/100ml plasma, 20% of proteins
-General 4-chain structural unit = 160kDA
-Immune response (antigen binding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Fibrinogen

A

-0.2-0.4g/100ml plasma, 10% proteins
MW = 340kDA, 30000 amino acids, 6 polypeptide chains
-Clotting response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Clot formation on medical implants (3 steps)

A
  1. protein adsorption
  2. platelet and leukocyte adhesion and activation
  3. thrombin generation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Initiating event

A

Rapid adsorption of plasma proteins such as fibrinogen is known to be the initiating event

34
Q

Platelets

A

-Occupy <1% of the blood volume – also called thrombocytes
-Their surface contains membrane-bound receptors which mediate surface adhesion and aggregation reactions
- They can bind to connective tissue in the activated state (e.g. collagen)

35
Q

Draw the coagulation cascade

A
36
Q

Intrinsic Pathway (Contact pathway) initiating step

A

attachment of multiple plasma proteins (serum proteases) on biomaterial
-surface contact (often negative charged surfaces)

37
Q

Intrinsic Pathway

A

-FXII absorbed to the surface autoactivation, to FXIIa
-converts prekallikrein to kallikrein and initiates coagulation and thrombin generation (cofactor high molecular weight kininogen HMWK)
-fibrin deposition on the surface
-thrombin promotes platelet activation
-platelet aggregates deposited on the surface are stabilized by fibrin strands to form a platelet-fibrin thrombus
-Kallikrein, thrombin, activate a local inflammatory response
-Leukocytes adhere to the surface

38
Q

Controlling clotting on medical implants

A
  1. Medical interventions
  2. Bioengineering solutions - Engineering blood/clot repellent surfaces
39
Q

Medical Interventions

A

-Prophylactic treatment with antiplatelet agents such as aspirin or clopidogrel or anticoagulants such as heparin or warfarin is often required to prevent complications induced from medical implants
-increases risk of bleeding (fatal)

40
Q

Bioengineering solution - Active approach

A

-deactivating factors/thrombin
-thrombin deactivation both inhibits the progress of the clotting cascade and up regulates natural anti-coagulation process (protein C inhibition of factor V)

41
Q

Bioengineering solutions - Passive approach

A

Use surface coating to indirectly prevent clot formation by preventing blood protein and cell adhesion (coating the surface of the implant with a lubricant infused coating or PEG)

42
Q

Thrombin deactivation (2 ways)

A

-directly binding deactivating agents to thrombin
-disrupting agents in the clotting cascade which are required for producing thrombin

43
Q

Thrombin deactivation by binding

A

Thrombin can be described schematically as having one catalytic center (fibrinogen - fibrin) and three binding sites:
1. catalytic center (active site)
2. fibrin binding site (exosite 2)
3. heparin-binding site
4. substrate recognition site (exosite 1)

44
Q

Heparin

A

-unfractionated heparin (UFH)
-highly sulfated naturally occurring glycosaminoglycan
-highest negative charge density of any molecule
-acts as a catalyst for antithrombin, increasing its activity

45
Q

What does Heparin do

A

binds to lysine sites on antithrombin resulting in conformational change in AT (supports binding of AT to active site of thrombin)
-inactivation by AT 1000x faster

46
Q

Low molecular weight heparin (LMWH)

A

-short chains of the polysaccharide with an average molecular weight of less than 8000Da
-LMWH is obtained by fractionation of polymeric heparin
-mainly inactivates FXa

47
Q

Medical advantages/disadvantages of LMWH to heparin

A

-molecular weight is lower
-need for only once or twice daily dosing
-lower risk of beading

48
Q

Oral direct thrombin inhibitors (DTI)

A

-Bind directly to thrombin and do not require a cofactor such as antithrombin to exert their effect
-can inhibit both soluble thrombin and fibrin-bound thrombin

49
Q

Oral direct Fxa inhibitors

A

-bind to the active site of FXa, which blocks the interaction with its substrate, inhibiting the final effects of thrombin generation

50
Q

Advantages of DOACs (direct oral anticoagulants)

A

-oral administration
-predictable effect
-lack of frequent monitoring or dose adjustment
-few known drug interactions

51
Q

Tissue factor pathway

A

blood comes in contact with traumatized vascular wall or extravascular tissues

52
Q

Anastomosis

A

connection made surgically between adjacent blood vessels, part of the intestine or other channels of the body

53
Q

Coagulopatic conditions

A

-due to external factors or genetics
-anticoagulant or blood thinning medication
-blood cancers
-long term use of antibiotics
-liver disease
-infection
-vitamin K deficiency
-haemophile (genetic factor difficiency)
-thrombocytopenia, low platelet count

54
Q

Hemostasis

A

acceleration of coagulation cascade to stop bleeding

55
Q

Injectables - Current strategy (hemostasis)

A

-prepolymer solution
-crosslinker (chemical, photo crosslinking, thermal, shear thinning)

56
Q

Patches (wound dressings) - Current strategy (hemostasis)

A

-Wet crosslinked hydrogels
-Dry planar membranes
-Microneedle arrays
-Electrospun mats
-Textiles and gauzes
-Sponges, aerogels, cryogels

57
Q

Powders - Current Strategy (hemostasis)

A

-clays, self-propelling particles

58
Q

Invasive current techniques

A

sutures, staples (damaging healthy tissue, scar formation, may need removal/replacement, unable to stop heavy bleeding, risk of infection)

59
Q

Non-invasive current techniques

A

wound dressings (bulky, chronic burn wounds, diabetic, decubitus)
adhesive tapes
zippers (only for external use, loss of adhesion upon wetting, low fatigue stability, only applicable to skin)

60
Q

Mechanism of hemostasis in hemostatic biomaterials

A

-negative charges activate factor XII
-Cationic charges promote adhesion to platelets
-Chemical bonding to bind platelets or RBCs or to activate coagulation factors
-Adsorption
1. Fast adsorption, charge simulation, physical sealing

61
Q

Acute vs Chronic Inflammation

A

Acute: considered to be early events occurring in the innate immune response

Chronic: occurs as a prolonged response after the initial immune response (acute) fails to clear the foreign body or resolve the effect

62
Q

Acute inflammation

A

-short response: minutes/days
-secretion of fluid and plasma proteins to site
-emigration of leukocytes (neutrophils, macrophages)
-phagocytosis and the release of proteolytic enzymes

63
Q

Main role of neutrophils in acute inflammation

A

phagocytose microorganisms/foreign materials
(1) recognition and attachment
(2) engulfment
(3) killing/degradation
(2)/(3) are biomaterial dependent

64
Q

leukocyte emigration assisted by____

A

adhesion molecules on leukocyte/endothelial surfaces
-surface expression of adhesion molecules can be induced/enhanced/altered by inflammatory agents/chemical mediators

65
Q

Acute inflammation biomaterial (time frame)

A

Biomaterials are not phagocytosed by neutrophils or macrophages because of the size (surface of the biomaterial is greater the cell) and if the biomaterial is non-degradable
-resolves less than 1 week
-beyond 1 week→ infection (chronic inflammation)

66
Q

Chronic Inflammation

A

-macrophages, monocytes , and lymphocytes , with the proliferation of blood vessels and connective tissue

67
Q

Reasons for chronic inflammation

A

-motion of the implant/infection
-chemical/physical properties of the biomaterial themselves
-toxic degradation products

68
Q

Most important cell in chronic inflammation

A

macrophage
-neutral proteases
-reactive oxygen metabolites
-coagulation factors
-growth-promoting factors → important to the growth of fibroblasts and blood vessels and the regeneration of epithelial cells

69
Q

Granulation Tissue

A

1 day following implantation of a biomaterial healing response is initiated by the action of monocytes and macrophages
-Fibroblasts and vascular endothelial cells in the implant site proliferate and begin to form granulation tissue

70
Q

Angiogenesis

A

Proliferation and formation of new small blood vessels of preexisting vessels
-Proliferation, maturation, and organization of endothelial cells into capillary vessels

71
Q

2 steps to granulation tissue

A

(1) Proliferation and formation of new small blood vessels of preexisting vessels→ Angiogenesis
(2) Fibroblast proliferation → active in synthesizing
collagen and proteoglycans (collagen forms the fibrous capsule, myofibroblasts secret and organize extracellular
matrix)

72
Q

Foreign-body reaction

A

foreign-body giant cells (FBGCs) and the components of granulation tissue (e.g., macrophages, fibroblasts), depending upon the form and topography of the implanted material.

73
Q

What determines the composition of Foreign Body reaction?

A

-surface properties (topography, chemical/physical properties) -size
-high surface area to volume implants have higher ratios of macrophages and FBGC than smooth surface implants

74
Q

Which step is frustrated phagocytosis part of

A

Acute inflammation

75
Q

Fibrosis/Fibrotic Encapsulation

A

Fibrosis (i.e., fibrotic encapsulation) surrounds the biomaterial/implant with its interfacial foreign-body reaction, isolating the implant and FBR from the local tissue environment.

76
Q

Local factors, wound healing

A
  • Anatomic site (tissue or organ) of implantation
  • The adequacy of blood supply
  • Potential for infection
77
Q

Systemic factors, wound healing

A
  • Nutrition
  • Preexisting diseases such as atherosclerosis, diabetes, and infection.
78
Q

Fibrosis/Fibrotic Encapsulation

A

fibrous capsule surrounding a biomaterial, may be a positive or negative response

79
Q

Advantages to development of fibrous capsule

A

-stabilize the biomaterial
-reduces motion of the implant relative to the tissue
(reduce the chronic inflammatory)
-Inadequate fibrous capsule - lead to migration

80
Q

Capsular contracture

A

excessive fibrotic capsule formation leading to stiffening and
distortion of the surrounding tissues as well as displacement of the breast implants